Dexamethasone and activators of the protein kinase A and C signal transduction pathways regulate neuronal calcitonin gene-related peptide expression and release
- 17 July 1995
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 686 (1), 77-86
- https://doi.org/10.1016/0006-8993(95)00461-x
Abstract
Primary cultures of adult rat dorsal root ganglia (DRG) neurons were used to determine if activation of either the protein kinase A or C signal transduction pathways or treatment with the synthetic glucocorticoid dexamethasone modulate neuronal calcitonin gene-related peptide (CGRP) synthesis and release. DRG are the sites of neuronal cell bodies known to produce abundant CGRP levels, and to send axons peripherally to blood vessels and centrally to the spinal cord. Using immunocytochemical techniques, we confirmed that synthesis of immunoreactive CGRP (iCGRP) is restricted to a subpopulation of DRG neurons. Subsequently, we determined that treatment (24 h) of the neurons with either dibutyryl cAMP (1 mM) or phorbol 12-myristate 13-acetate (2μM) increased CGRP mRNA content 2.2 ± 0.4 (n = 6, p < 0.03) and 3.0 ± 0.6-fold (n = 6, P < 0.02) respectively, while secreted iCGRP levels were increased 1.8 ± 0.2 (n = 14, P < 0.005) and 4.5 ± 1.0 (n = 14, P < 0.001)-fold over control levels. Treatment of the neurons with dexamethasone alone had no effect on CGRP expression; however, this agent was able to significantly attenuate the stimulatory effects of NGF on both CGRP mRNA accumulation and release of iCGRP. Time course studies demonstrated that in the phorbol ester treated neurons CGRP mRNA levels continued to increase at 48 h, while maximal induction with dibutyryl cAMP occurred at approximately 12 h. These results indicate that local and/or circulating factors which act through the protein kinase A and C signal transduction pathways upregulate both CGRP expression and release, while glucocorticoids attenuate the stimulatory effects of NGF.Keywords
This publication has 35 references indexed in Scilit:
- Enhanced Neuronal Expression of Calcitonin Gene–Related Peptide in Mineralocorticoid-Salt HypertensionHypertension, 1995
- Dexamethasone treatment reduces sensory neuropeptides and nerve sprouting reactions in injured teethPain, 1993
- Calcitonin gene-related peptide gene expression in the spontaneously hypertensive rat.Hypertension, 1993
- Bradykinin and inflammatory painTrends in Neurosciences, 1993
- Localization and Characterization of Calcitonin Gene-Related Peptide mRNA in Rat HeartThe American Journal of the Medical Sciences, 1992
- Calcitonin Gene-Related Peptide in the Regulation of Cardiac FunctionAnnals of the New York Academy of Sciences, 1992
- Effects of Dexamethasone, Calcium and 1,25-Dihydroxycholecalciferol on Calcitonin and Calcitonin Gene-Related Peptide mRNA Levels from the CA-77 C Cell LineThyroid®, 1992
- Systemic and regional hemodynamic effects of calcitonin gene-related peptide.Hypertension, 1987
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985
- Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processingNature, 1983